CompletedNCT00236379

Risperidone or olanzapine and blood sugar in schizophrenia

About this title

A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

Medication studyAges 18–65

The study in practice

Understand this study

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Study clarity

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: 59
Sponsor: Janssen, LP
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 4
Locations: Not clearly listed
Age range: From 18 Years to 65 Years
Official registry ID: NCT00236379
Official title: Show the full official title
A Six-month, Double-blind, Randomized, International, Multicenter Trial to Evaluate the Glucoregulatory Effects of Risperidone and Olanzapine in Subjects With Schizophrenia or Schizoaffective Disorder

Completed

Locations not listed

FAQ

Who is behind this study?

The study sponsor is Janssen, LP.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine and Risperidone.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.